Literature DB >> 9323153

Clinically aggressive metastasizing pleomorphic adenoma: report of two cases.

J Klijanienko1, A K El-Naggar, V Servois, J Rodriguez, P Validire, P Vielh.   

Abstract

BACKGROUND: It has been suggested that metastasizing pleomorphic adenomas may represent unrecognized malignancy.
METHODS: The cytologic and clinical characteristics of two metastasizing pleomorphic adenomas diagnosed by fine-needle sampling are reported.
RESULTS: Both showed malignant evolution: the primary tumors arose from the palate and the parotid salivary glands, respectively. Metastases occurred simultaneously with local recurrence in the first patient and after a second local recurrence in the second patient. Both patients were treated by surgery and radiotherapy but died of disseminated disease 8 and 4 years after initial diagnosis. No histologic evidence of malignancy was observed on cytology smears or histology sections in either case.
CONCLUSION: Clinically, our cases support the hypothesis that metastasizing pleomorphic adenomas represent unrecognized malignancy, because the biologic course of two tumors led to unequivocally lethal outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9323153     DOI: 10.1002/(sici)1097-0347(199710)19:7<629::aid-hed11>3.0.co;2-y

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date.

Authors:  Jan Ebbing; Carolin Blind; Harald Stein; Kurt Miller; Christoph Loddenkemper
Journal:  Rare Tumors       Date:  2009-12-28

2.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.